4.7 Article

Multifunctional Fe3O4/alumina core/shell MNPs as photothermal agents for targeted hyperthermia of nosocomial and antibiotic-resistant bacteria

Journal

NANOMEDICINE
Volume 6, Issue 8, Pages 1353-1363

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/NNM.11.34

Keywords

Fe3O4; hyperthermia; magnetic nanoparticle; near-infrared light; pathogenic bacteria; photothermal

Funding

  1. National Science Council of Taiwan

Ask authors/readers for more resources

The appearance of antibiotic-resistant bacterial strains is a serious problem in medical treatment. Thus, it is imperative to explore new therapeutic approaches and antibiotics with which to treat patients suffering from bacterial infections. Materials & Methods: In this work, we propose a targeted hyperthermia therapeutic approach using alumina-coated iron oxide magnetic nanoparticles (Fe3O4/alumina core/shell MNPs) as photothermal agents to selectively kill bacteria. Results: Fe3O4 MNPs possess photothermal capabilities under near-infrared (NIR) light illumination. The temperature of the MNP suspension (1.33 mu g/mu l, 60 mu l) under illumination with NIR light increased 20 degrees C over 5 min. Functionalization of the surface of the MNPs with an alumina coating allows them to have targeting capability toward bacteria. The prepared Fe3O4/alumina core/shell MNPs possess several desirable features, including magnetic properties, absorption capability in the NIR region and the ability to target bacteria. The magnetic properties of the Fe3O4/alumina MNPs allow conjugated target species to aggregate at a specific location under a magnetic field. A NIR laser can then be used to specifically irradiate the aggregated spot to photokill target bacteria. The cell growth of nosocomial bacteria, including Gram-positive, Gram-negative and antibiotic-resistant bacterial strains, can be effectively inhibited by over 95% within 10 min of light irradiation when targeted by Fe3O4/alumina MNPs. Conclusion: This approach provides a potential therapeutic approach for treating patients suffering from nosocomial and antibiotic-resistant bacterial infections.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available